Nano-X Imaging Ltd. header image

Nano-X Imaging Ltd.

NNOX

Equity

ISIN IL0011681371 / Valor 56410599

NASDAQ (2026-10-12)
USD 0.51-5.17%

Nano-X Imaging Ltd.
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Nano-X Imaging Ltd. is a NASDAQ-listed medical imaging company dedicated to making advanced diagnostic technologies more affordable and accessible, thereby promoting preventive healthcare. The company leverages its proprietary digital X-ray source and artificial intelligence to offer a comprehensive ecosystem that includes the Nanox.ARC Digital Tomosynthesis system, which provides cost-effective and user-friendly imaging, and Nanox.AI, which enhances CT scans by identifying early signs of chronic diseases. Additionally, Nano-X provides Nanox.CLOUD, a cloud-based platform for managing and analyzing imaging data, and Nanox.MARKETPLACE, a decentralized service that connects users with radiology and cardiology experts through teleradiology services. By integrating these technologies, Nano-X aims to streamline the imaging process from scan to diagnosis, improve early detection and treatment, and ultimately enhance health outcomes on a global scale.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-86.9%1Y
-91.9%3Y
-97.7%5Y

Performance

105%1Y
91.3%3Y
90.6%5Y

Volatility

Market cap

35 M

Market cap (USD)

Daily traded volume (Shares)

875,955

Daily traded volume (Shares)

1 day high/low

7.605 / 7

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Fagron SA
Fagron SA Fagron SA Valor: 3425437
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.89%EUR 22.20
Coloplast A/S
Coloplast A/S Coloplast A/S Valor: 20259063
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.15%DKK 455.90
Legend Biotech Corporation
Legend Biotech Corporation Legend Biotech Corporation Valor: 54834759
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.45%USD 17.88
Roivant Sciences Limited
Roivant Sciences Limited Roivant Sciences Limited Valor: 113331044
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.58%USD 33.35
Corcept Therapeutics Inc
Corcept Therapeutics Inc Corcept Therapeutics Inc Valor: 1812837
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.80%USD 117.80
2invest AG
2invest AG 2invest AG Valor: 110098281
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%EUR 7.68
The Platform Group AG
The Platform Group AG The Platform Group AG Valor: 57796644
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.43%EUR 0.88
Maternus-Kliniken AG
Maternus-Kliniken AG Maternus-Kliniken AG Valor: 335800
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.11%EUR 0.89
International Flavors & Fragrances Inc
International Flavors & Fragrances Inc International Flavors & Fragrances Inc Valor: 941876
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.81%USD 88.20
H. Lundbeck A/S
H. Lundbeck A/S H. Lundbeck A/S Valor: 119252587
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.34%DKK 46.92